Axol offer ready-made, well-characterized stem and functional cells complete with easy-to-understand protocols and video guides for handling them. We are devoted to making high quality, data-rich cellular products that are affordable for all research labs including starting up labs! We believe that all research labs should have easy access to the cells generated using the reprogramming and downstream differentiation technologies.
Contact Axol Bioscience today! www.axolbio.com
Contact Axol Bioscience today! www.axolbio.com
Location: United Kingdom
Employees: 11-50
Phone: +44 1223 751051
Total raised: $6.98M
Founded date: 2012
Investors 3
| Date | Name | Website |
| - | Amadeus Ca... | amadeuscap... |
| - | Cambridge ... | cambridgea... |
| - | Martlet | martletcap... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 20.01.2026 | - | $2.8M | - |
| 08.04.2022 | - | $4.18M | - |
Mentions in press and media 20
| Date | Title | Description |
| 17.04.2026 | Как приручить эндосимбионтов. Выращивание клеток и тканей вместо трансплантации | Когда-нибудь я хотел бы рассказать на Хабре о величайшей «инсайдерской сделке» в истории нашей планеты — как хлоропласты и митохондрии стали симбионтами эукариотов, а затем были ими порабощены, по-видимому, утратив большую часть генома и сн... |
| 19.02.2026 | Axol Bioscience makes third acquisition in five years | - |
| 20.01.2026 | Axol Bioscience secures $2.8m funding | - |
| 14.01.2026 | Axol Bioscience Secures $2.8M for US Expansion, iPSC Innovation | Axol Bioscience secured $2.8 million in funding, spearheaded by BroadOak Capital Partners and supported by the Roslin Foundation. This capital infusion targets aggressive US expansion and vital product development. The focus is on advanced ... |
| 14.01.2026 | Axol Bioscience Raises $2.8M in Funding | Axol Biosciences, an Edinburgh, Scotland, UK-based provider of induced pluripotent stem cell (iPSC) technologies for drug discovery and disease research, raised $2.8M in funding. The round was led by BroadOak Capital Partners, with particip... |
| 13.01.2026 | Axol Bioscience raises $2.8M to advance US expansion and product development | Financing led by US life sciences investor, BroadOak Capital Partners Investment to support expansion of US operations, product development, and cell manufacturing scale-up Cambridge / Edinburgh, UK, 13th January 2026: Axol Bioscience Ltd. ... |
| 13.01.2026 | Axol Bioscience: $2.8 Million Raised To Accelerate US Expansion And Scale iPSC Cell Manufacturing | Axol Bioscience announced it has raised $2.8 million (£2.1 million) in funding to expand its US operations, advance product development, and scale cell manufacturing capacity. The financing was led by US life sciences investor BroadOak Capi... |
| 08.04.2022 | Axol Bioscience raises £3.2 million GBP | Cambridge, UK: Axol Bioscience Ltd. (Axol), an established provider of iPSC-derived cells, media, and characterization services for life science discovery, announces that it has raised £3.2 million GBP (circa $4.2 million USD) in the extens... |
| 08.04.2022 | Axol Bioscience raises £3.2 million GBP | - |
| 08.04.2022 | Axol Bioscience Raises £3.2M In Funding | Axol Bioscience Ltd., a Cambridge, England, UK-based provider of iPSC-derived cells, media, and characterization services for life science discovery, raised £3.2m GBP (circa $4.2m USD). The round, the extension of its previous funding round... |
Show more